{"id":"https://openalex.org/W2085495677","doi":"https://doi.org/10.1097/00132580-200203000-00010","title":"Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia","display_name":"Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia","alternate_titles":[],"publication_year":2002,"publication_date":"2002-03-01","ids":{"openalex":"https://openalex.org/W2085495677","doi":"https://doi.org/10.1097/00132580-200203000-00010","mag":"2085495677","pmid":"https://pubmed.ncbi.nlm.nih.gov/11975844"},"language":"en","primary_location":{"id":"doi:10.1097/00132580-200203000-00010","doi":"https://doi.org/10.1097/00132580-200203000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00132580-200203000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S156649111","display_name":"Heart Disease","issn_l":"1521-737X","issn":["1521-737X","1533-3973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2085495677"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086716907","display_name":"Eric K. Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119942576","display_name":"University of the Pacific","ror":"https://ror.org/05ma4gw77","country_code":"US","type":"education","lineage":["https://openalex.org/I119942576"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric K. Gupta","raw_affiliation_strings":["University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences, Stockton, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences, Stockton, California, USA","institution_ids":["https://openalex.org/I119942576"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028439948","display_name":"Matthew K. Ito","orcid":"https://orcid.org/0000-0003-4264-2274","observed_orcids":["https://orcid.org/0000-0003-4264-2274"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew K. Ito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.891,"has_fulltext":false,"cited_by_count":48,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.70868114,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"4","issue":"2","first_page":"124","last_page":"137"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/extended-release-niacin","display_name":"extended-release niacin","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8100000023841858},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8019999861717224},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8360000252723694},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9359999895095825},{"id":"https://openalex.org/keywords/flushing","display_name":"flushing","score":0.671999990940094},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.6600000262260437},{"id":"https://openalex.org/keywords/coronary-heart-disease-prevention","display_name":"coronary heart disease prevention","score":0.949999988079071},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.3779999911785126},{"id":"https://openalex.org/keywords/niaspan","display_name":"Niaspan","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-nomenclature","display_name":"drug names","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2780092750","wikidata":"https://www.wikidata.org/wiki/Q134658","display_name":"Niacin","level":2,"score":0.9775481224060059},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.9119042158126831},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.730826735496521},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.6612682342529297},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5620943307876587},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5231179594993591},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.45956140756607056},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.399615079164505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3175293803215027},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.28027594089508057},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.07924550771713257}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00132580-200203000-00010","doi":"https://doi.org/10.1097/00132580-200203000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00132580-200203000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S156649111","display_name":"Heart Disease","issn_l":"1521-737X","issn":["1521-737X","1533-3973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart Disease","raw_type":"journal-article"},{"id":"pmid:11975844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11975844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart disease (Hagerstown, Md.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W38523360","https://openalex.org/W120724480","https://openalex.org/W137344628","https://openalex.org/W161185989","https://openalex.org/W1965408926","https://openalex.org/W1969277115","https://openalex.org/W1988179941","https://openalex.org/W1991444446","https://openalex.org/W1994248024","https://openalex.org/W2005786831","https://openalex.org/W2015873233","https://openalex.org/W2019699143","https://openalex.org/W2028737910","https://openalex.org/W2029199356","https://openalex.org/W2037328752","https://openalex.org/W2037627305","https://openalex.org/W2046991199","https://openalex.org/W2052740563","https://openalex.org/W2054688528","https://openalex.org/W2055318521","https://openalex.org/W2056809784","https://openalex.org/W2057867780","https://openalex.org/W2060409824","https://openalex.org/W2074972512","https://openalex.org/W2078489774","https://openalex.org/W2089286420","https://openalex.org/W2100233089","https://openalex.org/W2100447241","https://openalex.org/W2108668893","https://openalex.org/W2115572248","https://openalex.org/W2122099263","https://openalex.org/W2123188875","https://openalex.org/W2129750583","https://openalex.org/W2134799129","https://openalex.org/W2136841005","https://openalex.org/W2145799136","https://openalex.org/W2146318670","https://openalex.org/W2152086330","https://openalex.org/W2155598961","https://openalex.org/W2160689800","https://openalex.org/W2161721693","https://openalex.org/W2164534481","https://openalex.org/W2322095705","https://openalex.org/W2324712847","https://openalex.org/W2328529137","https://openalex.org/W2339031854","https://openalex.org/W2725187802","https://openalex.org/W4238251256","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W1984604944","https://openalex.org/W1984466880","https://openalex.org/W2139010961","https://openalex.org/W2155499238","https://openalex.org/W2027750202","https://openalex.org/W2027754732","https://openalex.org/W2119892847","https://openalex.org/W4240846314","https://openalex.org/W1602268667","https://openalex.org/W2053599662"],"abstract_inverted_index":{"Advicor":[0,366],"(lovastatin":[1],"and":[2,30,33,54,63,82,157,192,224,262,278,287,336,365,386,410],"extended-release":[3,69],"niacin)":[4],"is":[5,180],"the":[6,15,86,128,255,258,267,270,282,300,307,350,353,384,388,403,415],"first":[7],"cholesterol-lowering":[8],"combination":[9,94,129],"product":[10,95,130],"to":[11,76,97,104,132,177,209,315,378,382,400,402,412,414],"become":[12],"available":[13,221,228],"for":[14,43,118,204,284,302,338,352],"management":[16],"of":[17,47,115,125,137,151,163,186,215,257,269,281,309,355],"hyperlipidemia.":[18],"Lovastatin":[19,53],"significantly":[20,27],"lowers":[21,28],"low-density":[22,167],"lipoprotein":[23,31,37,168],"cholesterol,":[24],"whereas":[25],"niacin":[26,55,70,174,187,207,216,235,292,344,408],"triglycerides":[29],"(a)":[32],"markedly":[34],"increases":[35],"high-density":[36],"cholesterol.":[38],"These":[39,326],"effects":[40,79,89,106],"are":[41,220,227,237,245,312,324,328,358],"ideal":[42],"managing":[44],"a":[45,73,112,160],"variety":[46],"lipid":[48],"disorders,":[49],"including":[50],"metabolic":[51],"syndrome.":[52],"reduce":[56],"coronary":[57],"heart":[58],"disease":[59],"mortality":[60],"in":[61,111,120,159,306],"primary":[62],"secondary":[64],"prevention":[65],"patients,":[66],"respectively.":[67],"The":[68,93,171,289,372],"component":[71],"uses":[72],"unique":[74],"technology":[75],"minimize":[77],"adverse":[78,105],"(e.g.,":[80],"flushing":[81,109],"hepatotoxicity)":[83],"while":[84],"retaining":[85],"same":[87],"lipid-altering":[88],"as":[90,117,240,333],"immediate-release":[91,199,391],"niacin.":[92,392],"appears":[96],"be":[98,210],"well":[99],"tolerated,":[100],"with":[101,144],"discontinuation":[102],"due":[103,131],"other":[107],"than":[108,198],"occurring":[110],"similar":[113],"percent":[114],"patients":[116,126,164],"lovastatin":[119],"clinical":[121],"trials.":[122],"Approximately":[123],"9%":[124],"discontinued":[127],"flush.":[133],"No":[134],"confined":[135],"cases":[136],"myopathy":[138],"or":[139],"hepatotoxicity":[140],"have":[141,295,346],"been":[142,297,347,376],"reported":[143],"this":[145,250,394],"product.":[146],"Once-daily":[147],"dosing":[148],"provides":[149],"ease":[150],"administration":[152],"that":[153,219,226,273],"should":[154],"improve":[155],"compliance":[156],"result":[158],"greater":[161],"proportion":[162],"meeting":[165],"their":[166,331],"cholesterol":[169],"goals.":[170],"nomenclature":[172],"surrounding":[173],"products":[175,276,345,381,389],"used":[176],"treat":[178],"dyslipidemias":[179],"confusing.":[181],"While":[182],"only":[183],"two":[184,213,341,380],"types":[185,214],"formulations":[188,191,193,208],"exist":[189],"(immediate-release":[190],"which":[194],"dissolve":[195],"more":[196],"slowly":[197,205,233,290,342,406],"formulations),":[200],"government":[201],"regulations":[202],"allow":[203],"dissolved":[206,234,291],"divided":[211],"into":[212],"products;":[217],"those":[218,225],"over-the-counter":[222],"(OTC)":[223],"by":[229,299,349],"prescription":[230],"only.":[231],"Over-the-counter":[232],"preparations":[236],"not":[238,264,296],"classified":[239],"OTC":[241],"per":[242],"se,":[243],"but":[244],"considered":[246],"\"nutritional":[247],"supplements\".":[248],"For":[249],"reason,":[251],"they":[252,313,357],"fall":[253,265],"under":[254,266],"jurisdiction":[256],"Federal":[259],"Trade":[260],"Commission":[261],"do":[263],"umbrella":[268],"FDA":[271,301,351,404,419],"branch":[272],"controls":[274],"dyslipidemic":[275],"(Endocrine":[277],"Metabolic":[279],"Division":[280],"Center":[283],"Drug":[285],"Evaluation":[286],"Research).":[288],"nutritional":[293,416],"supplements":[294,417],"reviewed":[298],"safety":[303],"nor":[304,311],"efficacy":[305],"treatment":[308,354],"dyslipidemia":[310],"required":[314],"meet":[316],"generic":[317],"drug":[318],"rules":[319],"(even":[320],"though":[321],"various":[322],"brands":[323,327],"available).":[325],"described":[329],"on":[330],"labels":[332],"\"sustained-release\",":[334],"\"timed-release\",":[335],"\"slow-release\"":[337],"example.":[339],"Only":[340],"absorbed":[343],"approved":[348,405],"dyslipidemia;":[356],"Niaspan":[359],"(Kos":[360,367],"Pharmaceuticals,":[361,368],"Inc.,":[362,369],"Miami,":[363,370],"FL)":[364],"FL).":[371],"term":[373],"\"extended-release\"":[374,399],"has":[375],"given":[377],"these":[379],"simplify":[383],"terminology":[385],"differentiate":[387],"from":[390],"In":[393],"review,":[395],"we":[396],"will":[397],"use":[398],"refer":[401,413],"dissolving":[407],"preparation":[409],"\"sustained-release\"":[411],"(not":[418],"approved).":[420]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2085495677","counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
